AEROPORTO GUGLIELMO MARC... Quote - ADB | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Italy
BIT
AEROPORTO GUGLIELMO MARCONI DI BOLOGNA (ADB) Share Price

AEROPORTO GUGLIELMO MARCONI DI BOLOGNA (ADB)

7.38

-0.06

(-0.81%)

Closed November 07 10:30AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

7.38

Bid

7.34

Ask

7.48

Volume

5,890

7.30 Day's Range 7.44

7.26 52 Week Range 8.42

Market Cap

Previous Close

7.44

Open

7.34

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

6,771

Shares Outstanding

36,125,665

Dividend Yield

3.58%

PE Ratio

33.13

Earnings Per Share (EPS)

0.46

Revenue

145.06M

Net Profit

16.71M

Sector

Airports & Terminal Services

Industry

Airports & Terminal Services

Website

www.bologna-airport.it

Headquarters

Bologna, Bologna, Ita

Founded

-

AEROPORTO GUGLIELMO MARCONI DI BOLOGNA is listed in the Airports & Terminal Services sector of the Italian Stock Exchange with ticker ADB. The last closing price for AEROPORTO GUGLIELMO MARC... was 7.44 €. Over the last year, AEROPORTO GUGLIELMO MARC... shares have traded in a share price range of 7.26 € to 8.42 €.

AEROPORTO GUGLIELMO MARC... currently has 36,125,665 shares outstanding. The market capitalization of AEROPORTO GUGLIELMO MARC... is 268.77 € million. AEROPORTO GUGLIELMO MARC... has a price to earnings ratio (PE ratio) of 33.13.

Interim Report

RNS Number:3681S Abbey National Dublin Inv. II 21 November 2003 Abbey National Dublin Investment Fund II Plc 21st November, 2003 Re: Interim Report, Directors' Reports and...

Interim Report

RNS Number:4890N Abbey National Dublin Inv. II 11 July 2003 Abbey National Dublin Investment Fund II Plc 11th July, 2003 Re: Interim Report and Unaudited Financial Statements...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-1.07238605898	7.46	7.48	7.28	2028	7.43104339	DE
4	-0.32	-4.15584415584	7.7	8	7.26	11697	7.5097908	DE
12	-0.4	-5.14138817481	7.78	8	7.26	6771	7.61604901	DE
26	-0.6	-7.51879699248	7.98	8.18	7.26	5172	7.7570188	DE
52	-0.68	-8.43672456576	8.06	8.42	7.26	5195	7.90374741	DE
156	-2.32	-23.9175257732	9.7	9.84	6.82	5160	8.19169958	DE
260	-4.42	-37.4576271186	11.8	12.4	5.4	8493	8.76573513	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WTFINTrevi Finanziaria Industriale Spa	1.30 € (30.01%)	5.88k
WISC24Integrated System Credit Consulting Fintech Spa	0.0078 € (30.00%)	6k
WSBCCSicily by Car SpA	0.0623 € (29.79%)	497
WDIT24Destination Italia Spa	0.0006 € (20.00%)	26k
1SMCISuper Micro Computer Inc	22.64 € (18.97%)	5.6k
1ADJAdler Group SA	0.357 € (-16.20%)	3.1k
1BYNDBeyond Meat Inc	5.472 € (-11.00%)	1.34k
ESAUEsautomotion SPA	3.05 € (-10.82%)	3.5k
RDFRedelfi SpA	4.58 € (-10.20%)	239.98k
1AFAir FranceKLM	7.974 € (-9.76%)	73.9k
ISPIntesa Sanpaolo Spa	3.8535 € (-2.98%)	110.23M
TITTelecom Italia SpA	0.2259 € (0.31%)	103.95M
BAMIBanco BPM SpA	6.896 € (9.25%)	49.83M
ENELEnel Spa	6.673 € (-2.08%)	33.96M
SPMSaipem Spa	2.267 € (0.80%)	27.88M

bigsur25

bigsur25 4 minutes ago

60 Days , sixty days to get a solid position , it appears MONI has a long fuse quick flippers will get board and complain .

Bubae

Bubae 5 minutes ago

Looking at the daily volume Continuation Capital probably hasn't even worked through their first 60,200,000 share tranche for fees and expenses yet. Looks like there are buyers in volume for those shares at $0.0015. I would say that there will be all you could ever want available at that price.

Jab44

Jab44 7 minutes ago

So predictable. The 280MM yearly sales projection was never going to be achieved, thus Foley was running out of time.
Now the $6.66 will go down.
I expect to see this case study in a Harvard Business Review someday.

DewDiligence

DewDiligence 8 minutes ago

RVNC 3Q24 results (FWIW):

https://investors.revance.com/investors/Press-Releases/news-details/2024/Revance-Reports-Third-Quarter-2024-Financial-Results-Provides-Corporate-Update/default.aspx

• 3Q24 product sales (Daxxify + dermal fillers) were $58.8M, -10% QoQ and +9%

MiamiGent

MiamiGent 10 minutes ago

Solid link. A refuge in our hectic day.

mascale

mascale 10 minutes ago

Balfour Project drilling, 2022 report, is public information. The Extract at Hiru shows a Comparable transactions analysis--for the shareholder report it is likely for. Other matters appear to be public information for some length of time. It is likely that legal counsel--one or more--is involved

Chrism0000

Chrism0000 11 minutes ago

It's about getting favors from the FDA who is run by the government money talks bull sh walks

Zorax

Zorax 11 minutes ago

Is this your proof that the company is scamming us We don't need no proof. The company will supply that for us.
Cause all the 🤥🤡🤡🤡 in the company itself.

BadaBingPebble

BadaBingPebble 12 minutes ago

Holding them accountable for their own statements isn't negative. It's called accountability. I can't imagine a scenario where any investor wouldn't want that; except for you of course. Keep on begging for your 2's though....

BottomBounce

BottomBounce 12 minutes ago

Silver eyes $50 in 2025 as industrial demand grows and gold-silver ratio narrows
$GLD $GDX $GDXJ $NUGT $BAR $PSLV

BottomBounce

BottomBounce 12 minutes ago

Silver eyes $50 in 2025 as industrial demand grows and gold-silver ratio narrows
$GLD $GDX $GDXJ $NUGT $BAR $SLV

DR_rugby

DR_rugby 12 minutes ago

The thump is getting louder

https://lindemannlaw.ch/insights/litigation-against-credit-suisse-ubs-current-status-and-legal-developments/

Sooner or later they will have to pay out these contracts, termination and close the settlements thoughout the system

Idiot Mayor

Idiot Mayor 13 minutes ago

Well, so much for that theory. Looks like another three months of short attacks.

Gmenfan

Gmenfan 13 minutes ago

DewDiligence

DewDiligence 14 minutes ago

In the same section of RVNC’s 10-Q, it says that the Crown acquisition might not go through, which I consider the best-case scenario despite the uncertainty of such an outcome.

alwayswatching1

alwayswatching1 14 minutes ago

JustGoDeep

JustGoDeep 15 minutes ago

Honorable Mention, Post-Of-The-Day #2, Must Read.

CrashOverride

CrashOverride 15 minutes ago

UK was the right startup environment whilst the FDA will certainly love a nontoxic cure for cancer developed by non BP entity.

BadaBingPebble

BadaBingPebble 15 minutes ago

I'm happy to take that wager anytime any day. And, I'd be willing wager I'm sitting on substantially more shares than you.

Whalatane

Whalatane 15 minutes ago

Mr Mister To the best of my knowledge , generic Renvela is the serum pho drug most prescribed to dialysis patient .
It cost about $1 per capsule and most patients need 2-3 with each meal ...so $6- $9 a day ...... max of $270 a month
Most patients don't like Renvela ( it does work

Longstrongsilver

Longstrongsilver 15 minutes ago

No idea. You’d have to ask the IR guy. You might have better luck than me as apparently he doesn’t even read what I write before replying and telling me to shut up lol. Also don’t tie your carriage to tight to my horse . My query was sincere. I’m not sure if yours are too or you are just a basher.

JustGoDeep

JustGoDeep 16 minutes ago

Honorable Mention, Post-Of-The-Day #1, Must Read.

northam43

northam43 16 minutes ago

Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/7/uhqig2_Completed_Cycles.PNG

meidiot

meidiot 16 minutes ago

I will keep my 10 shares and keep an eye on an UNHINGED CEO.

AEROPORTO GUGLIELMO MARC...

Eco (atlantic) Oil & Gas

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions